Skip to main content
. Author manuscript; available in PMC: 2013 Dec 13.
Published in final edited form as: Neuroscience. 2012 Sep 19;226:427–440. doi: 10.1016/j.neuroscience.2012.09.030

Table 2.

Mean (±SEM) head-down sniffing counts of DMSO- and EEDQ-treated preweanling rats (n = 8 per group) on time blocks 9–16 (Experiment 2)

DMSO Condition
Nonprotected SCH/Sul Protection
 0 μg NPA 0.39 (±0.20) 0 μg NPA 0.72 (±0.31)
 10 μg NPA 9.17 (±0.55)* 10 μg NPA 11.03 (±0.64)*
 20 μg NPA 11.76 (±0.66)* 20 μg NPA 13.45 (±0.46)*
EEDQ Condition
Nonprotected SCH/Sul Protection
 0 μg NPA 0.95 (±0.39) 0 μg NPA 1.03 (±0.46)
 10 μg NPA 4.17 (±0.59)* 10 μg NPA 11.05 (±0.41)*
 20 μg NPA 2.17 (±0.88) 20 μg NPA 13.33 (±0.28)*

Head-down sniffing values represent mean scores per 5-min time block during the final 40-min testing phase.

*

Significantly different from the 0 μg NPA group in the same treatment condition;

Significantly different from the 10 μg NPA group in the same treatment condition;

Significantly different from rats in the EEDQ-nonprotected condition receiving the identical dose of NPA.